News
Publications
Stay up to date on the latest company news, publications and announcements.
First in Indiana to Use the allay™ Hydrogel Cap in a Combined Amputation Procedure
OrthoIndy · June 2026
First Indiana use of the allay™ Hydrogel Cap during a combined amputation and peripheral nerve procedure.
Neuroma Prevention with a Novel In Situ Forming Hydrogel in a Rat Sciatic Nerve Model
PRS Global Open · June 2026
Hydrogel nerve cap prevented neuroma formation in a preclinical rat model.
Symptomatic Trigeminal Neuroma: A Case Report
J. of Neurological Disorders & Stroke · April 2026
Hydrogel for treatment of a symptomatic trigeminal neuroma.
Multicenter Retrospective Analysis
ASPN · January 2026
Novel hydrogel for treatment and prevention of symptomatic neuroma.
Vizient Innovative Technology Contract
Tulavi Therapeutics · January 2026
Allay™ Hydrogel Cap awarded an Innovative Technology contract from Vizient.
First Peer-Reviewed Clinical Data
PRS Global Open · December 2025
A novel hydrogel for treatment and prevention of symptomatic neuroma: early clinical experience.
Indication Expanded to 25 kg and Above
Tulavi Therapeutics · October 2025
Allay™ Hydrogel Cap indication extended to smaller patients.
CEO Josh Vose Featured on Medsider
Tulavi Therapeutics · October 2025
Josh Vose joins the Medsider podcast to discuss peripheral nerve surgery.
Selected for Vizient Technology Exchange
Tulavi Therapeutics · August 2025
Allay™ Hydrogel Cap chosen to exhibit at the Vizient Innovative Technology Exchange.
Partnership with VHSS to Treat Veterans
Tulavi Therapeutics · July 2025
Bringing nerve treatment to veterans impacted by amputations and traumatic injuries.